Medical director
NeuroMax
Maxwell Biotech Group
Russian Federation
Graduated from First Moscow State Medical University named after I.M. Sechenov. Finished residency in Scientific Research Institute for ophthalmology diseases. Has more than 15 years of experience in research and medical analytics. Worked in international pharmaceutical companies such as “Novartis Pharma”, “AstraZeneca” with responsibilities for international clinical studies organization, scientific medical support in pipeline development, medical information analytics, interaction with pharmaceutical community. Has extensive experience in pre-clinical studies organization, support and organization of API and finished drug product manufacturing. In 2014, joined «Maxwell Biotech Group» team and has been leading the projects of «Osteros Biomedica», «MetaMax» and one of the project «NeuroMax» companies since then. Responsible for clinical trials organization (from initial stage to project closure), implementation of product development strategy, vendors selection, study documents analysis and preparation.
Scientific Research in ophthalmology diseases